1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Logistic regression analysis for favorable clinical outcomea
mRS ≤2 at 2 Months Odds Ratio 95% CI P Value Clot location – – .003 ICA ref ref – M1 proximal 10.1 0.74–140 .08 M1 distal 33.8 2.9–428 .007 M2 and M3 115.8 7.7–1737 .001 Onset-to-treatment time 0.99 0.97–1.02 .44 Sex 0.34 0.09–1.3 .11 Age 0.95 0.90–0.99 .02 Admission NIHSS score 0.81 0.71–0.92 .001 Favorable CS (2–4) 9.3 2.4–35.8 .001
Note:—ref indicates reference location; –, not applicable.
↵a Odds ratios are per minute for onset-to-treatment time, per year for age, and per 1 point for NIHSS.